Definition
Lina M. Obeid (1962 – 2020) was an Azerbaijani‑American biomedical scientist renowned for her pioneering research on sphingolipid metabolism and its role in cell death, inflammation, and cancer. She held senior academic positions in the United States, including at the Medical University of South Carolina (MUSC) and the M.D. Anderson Cancer Center.
Overview
Obeid earned her doctorate in biochemistry and subsequently built a career focused on the biochemical pathways of sphingolipids, a class of lipids that serve as signaling molecules in diverse physiological and pathological processes. Her work demonstrated how metabolites such as ceramide and sphingosine‑1‑phosphate regulate apoptosis (programmed cell death) and cancer progression. Over a span of three decades, she authored more than 200 peer‑reviewed publications, secured substantial research funding from the National Institutes of Health (NIH) and private foundations, and mentored numerous graduate students and postdoctoral fellows. Obeid was a member of several professional societies, including the American Association for Cancer Research (AACR), and received honors such as the AACR–Merck Award for Basic Cancer Research (2005).
Etymology/Origin
The given name Lina derives from multiple linguistic traditions, often interpreted as a diminutive of names ending in “‑lina” (e.g., Carolina) or from Arabic roots meaning “tender” or “soft.” The surname Obeid (also rendered Ubaid or Obeid) originates from the Arabic word “ʿUbayd,” meaning “little servant” or “devoted,” and is common in various Middle‑Eastern and North‑African populations. In Obeid’s case, biographical sources indicate an Azerbaijani heritage.
Characteristics
- Research Focus: Elucidation of sphingolipid metabolic pathways, particularly the enzymatic conversion of ceramide to sphingosine‑1‑phosphate and its impact on cellular signaling.
- Key Contributions: Identification of ceramide as a pro‑apoptotic messenger; discovery of the “sphingolipid rheostat” concept describing the balance between ceramide and sphingosine‑1‑phosphate in determining cell fate; demonstration of sphingolipid involvement in inflammatory responses and tumor biology.
- Academic Positions: Professor of Biochemistry at MUSC; Director, Center for Cancer Research; former faculty member at the University of Texas MD Anderson Cancer Center.
- Publications & Impact: Over 200 scientific articles, an h‑index exceeding 60, and citation counts surpassing 30,000, reflecting broad influence across cell biology, oncology, and pharmacology.
- Mentorship & Leadership: Supervised numerous doctoral candidates; served on editorial boards of journals such as Journal of Lipid Research and Cell.
Related Topics
- Sphingolipid metabolism
- Ceramide signaling
- Sphingosine‑1‑phosphate (S1P) receptors
- Apoptosis and programmed cell death mechanisms
- Cancer biology and tumor microenvironment
- Lipidomics and mass‑spectrometry–based lipid analysis
- Biomedical research funding and translational oncology initiatives